Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study - Buser, K S; Joss, R A; Piquet, D (Ann Oncol, 1993)
et al.